- Is HBsAg Loss an Ideal End-point of Oral Antiviral Therapy in Chronic Hepatitis B Patients?
-
Kang K, Kim JH
- KMID: 2155334
- Korean J Gastroenterol.
- 2014 May;63(5):329-332.
- doi: 10.4166/kjg.2014.63.5.329
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status and Clinical Course of Hepatitis C Virus in Korea
-
Kwon JH, Bae SH
- KMID: 1767540
- Korean J Gastroenterol.
- 2008 Jun;51(6):360-367.
The mortality due to chronic liver disease, including liver cirrhosis and hepatocellular carcinoma (HCC), ranks as one of the highest in Korea. The prevalence rates of hepatitis C virus (HCV)... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study
-
Zeng QL, Li B, Zhang XX, Chen Y, Fu YL, Lv J, Liu YM, Yu ZJ
- KMID: 2412102
- Gut Liver.
- 2016 Nov;10(6):955-961.
- doi: 10.5009/gnl15321
BACKGROUND/AIMS: No clinical model exists to predict the occurrence of hepatocellular carcinoma in sustained virologic response-achieving (HCC after SVR) patients with chronic hepatitis C (CHC). METHODS: We performed a case-control study... -
- CITED
-
- Close
- SHARE
-
- Close
- Gene Expression Profile in Response to Hepatitis B Virus X Gene by Using an Adenoviral Vector
-
Joo HY, Han KH, Ryu WS
- KMID: 863112
- Korean J Hepatol.
- 2002 Dec;8(4):371-380.
BACKGROUND/AIMS: Hepatitis B virus (HBV) is the etiological factor for hepatocellular carcinoma (HCC). Numerous evidence has indicated a link between chronic infection with HBV and the development of HCC.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
-
Sinn DH, Lee JH, Kim K, Ahn JH, Lee JH, Kim JH, Lee DH, Yoon JH, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2412233
- Gut Liver.
- 2017 Jul;11(4):528-534.
- doi: 10.5009/gnl16403
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) can develop in chronic hepatitis B (CHB) patients with normal alanine aminotransferase (ALT) levels. Therefore, methods that can stratify an individual's HCC risk are needed. METHODS: A... -
- CITED
-
- Close
- SHARE
-
- Close
- Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
-
Shim JJ, Oh IH, Kim SB, Kim JW, Lee CK, Jang JY, Lee JS, Kim BH
- KMID: 2412103
- Gut Liver.
- 2016 Nov;10(6):962-968.
- doi: 10.5009/gnl15426
BACKGROUND/AIMS: The benefit of oral antiviral therapy in preventing hepatocellular carcinoma (HCC) in the general population is not well understood. We used a novel prediction method to estimate the risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis
-
Wu C, Liu L, Zhao P, Tang D, Yao D, Zhu L, Wang Z
- KMID: 2234074
- Gut Liver.
- 2015 Sep;9(5):665-671.
- doi: 10.5009/gnl14212
BACKGROUND/AIMS: To screen for serum protein/peptide biomarkers of hepatitis B virus (HBV)-associated chronic hepatic lesions in an attempt to profile the progression of HBV-associated chronic hepatic lesions using surface-enhanced laser... -
- CITED
-
- Close
- SHARE
-
- Close
